Insider Transactions in Q1 2023 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,023
-14.0%
|
$136,059
$133.22 P/Share
|
|
Mar 08
2023
|
Kim Sablich EVP, GM of U.S. |
SELL
Open market or private sale
|
Direct |
3,013
-4.59%
|
$418,807
$139.81 P/Share
|
|
Mar 07
2023
|
Kenneth W O'Keefe Director |
SELL
Open market or private sale
|
Direct |
2,690
-10.52%
|
$371,220
$138.39 P/Share
|
|
Mar 07
2023
|
Kenneth W O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+14.96%
|
$364,500
$81.76 P/Share
|
|
Mar 07
2023
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
2,075
-8.7%
|
$290,500
$140.76 P/Share
|
|
Mar 06
2023
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
1,706
-6.67%
|
$243,958
$143.92 P/Share
|
|
Mar 06
2023
|
Finbar Larkin SVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,706
+6.26%
|
$98,948
$58.72 P/Share
|
|
Mar 05
2023
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,426
-8.98%
|
$770,492
$142.78 P/Share
|
|
Mar 05
2023
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,274
-4.66%
|
$322,908
$142.78 P/Share
|
|
Mar 05
2023
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,148
-13.57%
|
$160,720
$140.76 P/Share
|
|
Mar 05
2023
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,557
-3.43%
|
$221,094
$142.78 P/Share
|
|
Mar 05
2023
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,923
-5.3%
|
$273,066
$142.78 P/Share
|
|
Mar 05
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,020
-13.31%
|
$286,840
$142.78 P/Share
|
|
Mar 05
2023
|
Kim Sablich EVP, GM of U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,610
-4.58%
|
$228,620
$142.78 P/Share
|
|
Mar 05
2023
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,882
-5.34%
|
$3,107,244
$142.78 P/Share
|
|
Mar 04
2023
|
Seamus Mulligan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+0.38%
|
$265,500
$59.13 P/Share
|
|
Mar 03
2023
|
Finbar Larkin SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,373
+15.49%
|
-
|
|
Mar 03
2023
|
Daniel N Swisher Jr President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
13,456
+18.21%
|
-
|
|
Mar 03
2023
|
Robert Iannone EVP, Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
12,447
+20.33%
|
-
|
|
Mar 03
2023
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,523
+22.98%
|
-
|
|
Mar 03
2023
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
12,784
+21.99%
|
-
|
|
Mar 03
2023
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,419
+20.62%
|
-
|
|
Mar 03
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,870
+20.32%
|
-
|
|
Mar 03
2023
|
Kim Sablich EVP, GM of U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
10,429
+22.86%
|
-
|
|
Mar 03
2023
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
42,388
+9.38%
|
-
|
|
Feb 02
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
531
-4.48%
|
$83,367
$157.26 P/Share
|
|
Feb 02
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
531
+4.29%
|
$57,879
$109.45 P/Share
|
|
Feb 01
2023
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$155,000
$155.79 P/Share
|
|
Jan 03
2023
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.4%
|
$477,000
$159.79 P/Share
|
|
Jan 03
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
531
-4.48%
|
$84,429
$159.59 P/Share
|
|
Jan 03
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
531
+4.29%
|
$57,879
$109.45 P/Share
|